| abstract |
Methods for Homogenizing Parvovirus B19 in Clinical SamplesVarious embodiments of the present invention relate to compositions and methods for analyzing a production pool of blood plasma, blood serum, and plasma-derived products, wherein anionic surfactant is added to the blood prior to analysis. Added to plasma, blood serum, or aliquots of the production pool, the counter ion of the anionic surfactant is not a sodium ion. The anionic surfactant may be, for example, lauryl sulfate. The counter ion of the anionic surfactant may be, for example, a lithium ion. |